+62.7%
EMR vs RCAT
+183.7%
-121.0%
-29.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | RCAT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.7% | -2.0% | +3.7% | +1.8% |
| 7D | -1.5% | -1.4% | -0.1% | -1.4% |
| 30D | -5.6% | -3.3% | -2.3% | -5.5% |
| 3M | +7.9% | -43.2% | +51.2% | +10.6% |
| 6M | +6.0% | -43.2% | +49.2% | +7.7% |
| YTD | +16.4% | +5.5% | +10.9% | +14.3% |
| 1Y | +16.6% | -1.6% | +18.3% | +14.0% |
| 3Y | +62.9% | +773.7% | -710.8% | +46.7% |
| All | +62.7% | +183.7% | -121.0% | +48.8% |
Cumulative growth
Daily Returns
Daily percentage return beside RCAT.
Daily Out/Under-Performance
Portfolio return minus RCAT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RCAT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded RCAT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling